When patients are given a choice, compliance nearly doubles1,2

Chart: 38% Colonoscopy Only, 69% Choice (FOBT, Colonoscopy)

Offer patients the choice of Cologuard®, an option with high sensitivity, high compliance, and patient satisfaction.

REFERENCE 1. Inadomi JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. 2012;172(7):575-582. 2. This study was done at a single health network in San Francisco comprising of a racially and ethnically diverse population; it was a 3-month cluster randomization design into 3 arms over an 18-month study period. Results varied by ethnicity.